CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III, randomized, double-blind, multicenter study

Background Concurrent chemoradiotherapy is the standard of care for locally advanced cervical cancer. Concurrent chemoradiotherapy with programmed blockade of the cell death-1/programmed cell death-ligand 1 pathway may promote a more immunogenic environment through increased phagocytosis, cell death...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayadev, Jyoti, Nunes, Ana T, Li, Mary, Marcovitz, Michelle, Lanasa, Mark C, Monk, Bradley J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398223/
https://www.ncbi.nlm.nih.gov/pubmed/32447296
http://dx.doi.org/10.1136/ijgc-2019-001135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398223/
https://www.ncbi.nlm.nih.gov/pubmed/32447296
http://dx.doi.org/10.1136/ijgc-2019-001135

Ejemplares similares